Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of adding a second dose of sertaconazole 300 mg vaginal ovule in pregnant women with acute vaginal candidiasis
TCTR20220121004Phase 3Completed
- Sponsor
- Pacific Health Care Organization
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sertaconazole nitrate in vulvovaginal candidiasis (VVC), sponsored by Pacific Health Care Organization. Started Feb 2022; status: completed.
02
Drugs
sertaconazole nitrate
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on TCTR20220121004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220121004.